GPC2 and pancreatic adenocarcinoma: Combining these results, we found that high GPC2 expression had a good prognosis in PAAD, BLCA, LGG, HNSC, ESCA, THYM, LAML, and GBM and a poor prognosis in COAD, ACC, SARC, KIRC, PRAD, MESO, LIHC, BRCA, UCEC, UVM, and THCA.